期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

寻常性银屑病患者血清肿瘤坏死因子α及其受体的检测 被引量：3

原文传递
导出
作者 高奎斌 李萍 梁再赋 王雅坤 宋芳吉 陈洪铎
机构地区 中国医科大学附属第一医院皮肤科 中国医科大学基础医学院生化检测中心
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2004年第3期165-165,共1页 Chinese Journal of Dermatology
基金 美国中华医学基金会资助课题(CMB#00-734)
关键词 寻常性银屑病 血清 肿瘤坏死因子Α 肿瘤坏死因子α受体 检测 酶联免疫吸附试验
分类号 R758.63 [医药卫生—皮肤病学与性病学]
  • 相关文献

参考文献6

  • 1Mussi A, Bonifati C, Carducci M, et al.Serum TNF-alpha levels correlate with disease severity and are reduced by effective therapy in plaque-type psoriasis. J Biol Regul Homeost Agents, 1997, 11: 115-118.
  • 2Asadullah K, Prosch S, Audring H, et al. A high prevalence of cytomegalovirus antigenaemia in patients with moderate to severe chronic plaque psoriasis: an association with systemic tumour necrosis factor alpha overexpression. Br J Dermatol, 1999, 141:94-
  • 3Tigalonova M, Bjerke JR, Gallati H, et al.Serum levels of interferons and TNF-alpha are not correlated to psoriasis activity and therapy. Acta Derm Venereol Suppl (Stockh), 1994, 186: 25-27.
  • 4Ettehadi P, Greaves MW, Wallach D, et al.Elevated tumour necrosis factor -alpha (TNF-alpha) biological activity in psoriatic skin lesions. Clin Exp Immunol, 1994, 96:146-151.
  • 5Partsch G, Wagner E, Leeb BF, et al. Upregulation of cytokine receptors sTNF-R55,sTNF-R75, and sIL-2R in psoriatic arthritis synovial fluid. J Rheumatol, 1998, 25:105-110.
  • 6楚瑞琦,刘平,谭升顺,彭振辉.银屑病的免疫生物学治疗进展[J].中华皮肤科杂志,2003,36(3):174-176. 被引量：10

二级参考文献27

  • 1Krueger JG;Walters IB;Miyazawa M.Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cellsby administration of humanized anti-Tac antibody to patients with psoriasis[J],2000(43).
  • 2Morel P;Revillard JP;Nicolas JF.Anti-CD4 monoclonal antibody therapy in severe psoriasis[J],1992.
  • 3Gottlieb AB;Lebwohl M;Shirin S.Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot multicenter multiple-do se placebo-controlled study[J],2000.
  • 4Oh C J;Das KM;Gottlieb AB.Treatment with anti-tumor necrosis factor alpha (TNF-alpha) monoclonal antibody dramat ically decreases the clinical activity of pso riasis lesions[J],2000(42).
  • 5Kirby B;Marsland AM;Carmichael A J.Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexate[J],2001.
  • 6Ogilvie AL;Antoni C;Dechant C.Treatment of psoriatic arthritis with antitu mour necrosis factor-alpha antibody clears skin lesions of psoriasis resistant to treat ment with methotrexate[J],2001.
  • 7Chaudhari U;Romano P;Mulcahy LD.Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial,2001(9271).
  • 8Mease PJ;Goffe BS;Metz J.Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial[J],2000.
  • 9Yazici Y;Erkan D;Lockshin MD.A pre liminary study of etanercept in the treat ment of severe resistant psoriatic arthritis,2000.
  • 10Zeltser R;Valle L;Tanck C.Clini cal histological and immunophenotypic characteristics of injection site reactions associated with etanercept:a recombinant tumor necrosis factor alpha receptor:Fc fusion protein,2001.

共引文献9

同被引文献37

引证文献3

二级引证文献14

中华皮肤科杂志
2004年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部